Most cited article(s)

You have access
To Scan or Not to Scan: An Unnecessary Dilemma for PSMA Radioligand Therapy
Sandy Srinivas and Andrei Iagaru

Journal of Nuclear Medicine November 1, 2021, 62 (11) 1487-1488; DOI: https://doi.org/10.2967/jnumed.121.263035
You have access
PSMA-Ligand PET for Early Castration-Resistant Prostate Cancer: A Retrospective Single-Center Study
Manuel Weber, Claudia Kurek, Francesco Barbato, Matthias Eiber, Tobias Maurer, Michael Nader, Boris Hadaschik, Viktor Grünwald, Ken Herrmann, Axel Wetter and Wolfgang P. Fendler

Journal of Nuclear Medicine January 1, 2021, 62 (1) 88-91; DOI: https://doi.org/10.2967/jnumed.120.245456
You have access
The Future of Nuclear Medicine, Molecular Imaging, and Theranostics
Wolfgang A. Weber, Johannes Czernin, Carolyn J. Anderson, Ramsey D. Badawi, Henryk Barthel, Frank Bengel, Lisa Bodei, Irène Buvat, Marcelo DiCarli, Michael M. Graham, Jan Grimm, Ken Herrmann, Lale Kostakoglu, Jason S. Lewis, David A. Mankoff, Todd E. Peterson, Heinrich Schelbert, Heiko Schöder, Barry A. Siegel and H. William Strauss

Journal of Nuclear Medicine December 1, 2020, 61 (Supplement 2) 263S-272S; DOI: https://doi.org/10.2967/jnumed.120.254532
You have access
Impact of ⁶⁸Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas
Manuel Röhrich, Patrick Naumann, Frederik L. Giesel, Peter L. Choyke, Fabian Staudinger, Annika Wefers, Dawn P. Liew, Clemens Kratochwil, Hendrik Rathke, Jakob Liermann, Klaus Herfarth, Dirk Jäger, Jürgen Debus, Uwe Haberkorn, Matthias Lang and Stefan A. Koerber

Journal of Nuclear Medicine June 1, 2021, 62 (6) 779-786; DOI: https://doi.org/10.2967/jnumed.120.253062
You have access
The Latest Developments in Imaging of Fibroblast Activation Protein
Annette Altmann, Uwe Haberkorn and Jens Siveke

Journal of Nuclear Medicine February 1, 2021, 62 (2) 160-167; DOI: https://doi.org/10.2967/jnumed.120.244806
You have access
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with ¹⁷⁷Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort
Jeremie Calais, Andrei Gafita, Matthias Eiber, Wesley R. Armstrong, Jeannine Gartmann, Pan Thin, Kathleen Nguyen, Vincent Lok, Laura Gosa, Tristan Grogan, Rouzbeh Esfandiari, Martin Allen-Auerbach, Andrew Quon, Shadfar Bahri, Pawan Gupta, Linda Gardner, David Ranganathan, Roger Slavik, Magnus Dahlbom, Ken Herrmann, Ebrahim Delpassand, Wolfgang P. Fendler and Johannes Czernin

Journal of Nuclear Medicine October 1, 2021, 62 (10) 1440-1446; DOI: https://doi.org/10.2967/jnumed.121.261982
You have access
Imaging the Cancer Immune Environment and Its Response to Pharmacologic Intervention, Part 2: The Role of Novel PET Agents
Amir Iravani and Rodney J. Hicks

Journal of Nuclear Medicine November 1, 2020, 61 (11) 1553-1559; DOI: https://doi.org/10.2967/jnumed.120.248823
You have access
PSMA Expression Assessed by PET Imaging Is a Required Biomarker for Selecting Patients for Any PSMA-Targeted Therapy
Jeremie Calais and Johannes Czernin

Journal of Nuclear Medicine November 1, 2021, 62 (11) 1489-1491; DOI: https://doi.org/10.2967/jnumed.121.263159
You have access
Risk of Bowel Obstruction in Patients with Mesenteric or Peritoneal Disease Receiving Peptide Receptor Radionuclide Therapy
Jonathan R. Strosberg, Taymeyah Al-Toubah, Eleonora Pellè, Johnna Smith, Mintallah Haider, Tai Hutchinson, Jason B. Fleming and Ghassan El-Haddad

Journal of Nuclear Medicine January 1, 2021, 62 (1) 69-72; DOI: https://doi.org/10.2967/jnumed.120.242875
You have access
One-Stop Shop: ¹⁸F-Flortaucipir PET Differentiates Amyloid-Positive and -Negative Forms of Neurodegenerative Diseases
Jochen Hammes, Gérard N. Bischof, Karl P. Bohn, Özgür Onur, Anja Schneider, Klaus Fliessbach, Merle C Hönig, Frank Jessen, Bernd Neumaier, Alexander Drzezga and Thilo van Eimeren

Journal of Nuclear Medicine February 1, 2021, 62 (2) 240-246; DOI: https://doi.org/10.2967/jnumed.120.244061

Main menu

User menu

Search

Most cited article(s)

Pages